Comment by
stockbuphoon on Aug 31, 2022 12:41pm
It's amazing that it isn't at 5 cents today? Does no one pay attention to these press releases? There will be no liquidity to sell off after they are removed. Thry shut 4050 and sold Ryplazim. What is left? Maybe a new version of 4050 in preclinical trial still years away from revenue or partner deal? Yet, Pritchard being paid as a $1B company valuation CEO. Incredible.
Comment by
Dibah420 on Sep 01, 2022 5:15pm
balain: Given the paucity of potential catalysts the only trick left for this pony is another reverse split. Let's say they do a 4:1 to bring the s/p up to $2. I give maybe 90 days for the shares to tank down to penny status...and, shortly thereafter, another delisting notice Bonne fete du tarvail!
Comment by
Damnre on Sep 02, 2022 6:38am
They have 5 months to recover